Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XILLIX FDA APPROVED -- Ignore unavailable to you. Want to Upgrade?

To: Edward W. Richmond who wrote (440)	7/19/1999 11:40:00 AM
From: hsg	Read Replies (1) \| Respond to of 572

I like the accurate projections as well (though not the projections themselves)...I reviewed an analyst report (with a strong buy) and it seems to indicate a falling revenue with a considerable accelaration next year...price target $3.40...rated as hugely undervalued....it fell below a buck this morning...if it falls much further I will buy more and just forget about the stock for the rest of the year...